483 Patheon Pharmaceuticals Mar 2011

483 Patheon Pharmaceuticals Mar 2011

Thomas Arista FDA, Michael Sheehan FDA, Anna Brannen FDA, Tracey Harris FDA$119.00 - Available Now

FDA investigators audited the Patheon Pharmaceuticals - Cincinnati, OH, United States facility and issued 3 inspectional observations (via FDA 483) on 24 Mar 2011.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 24 Mar 2011
  • Location: Cincinnati, United States
  • FEI: 1510437
Add To Cart